The chemical class referred to as SRrp130 Activators encompasses a diverse range of compounds that can influence the activity of SRrp130, a protein involved in RNA splicing and cellular signaling pathways. These activators operate through various mechanisms to modulate the function of SRrp130, which is crucial for the processing of pre-mRNA into mature mRNA. The compounds in this class target different enzymes and cellular structures that are either directly or indirectly involved in the regulation of SRrp130 activity. For instance, some chemicals in this group are known to inhibit specific kinases responsible for the phosphorylation of SR proteins, of which SRrp130 is a member. Phosphorylation is a critical post-translational modification that affects the protein's function, localization, and interaction with other cellular components. By altering the phosphorylation status of SRrp130, these activators can regulate its activity in mRNA splicing.
Additionally, other activators within this class bind to components of the spliceosome, the complex molecular machinery responsible for removing introns from pre-mRNA. By interacting with the spliceosome, these compounds can change the splicing pattern and, consequently, the activity of SRrp130. Moreover, some activators target signaling pathways that influence the cell cycle and cellular differentiation, processes that are intimately linked with mRNA processing and, by extension, SRrp130 function. Through these mechanisms, SRrp130 activators can affect the expression and maturation of a wide array of gene products, highlighting their significant role in gene expression regulation. It is the fine-tuning of SRrp130 activity by these activators that underscores the intricate control of splicing, a fundamental process critical for the proper expression of genes and the maintenance of cellular function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PD 166866 | 192705-79-6 | sc-208154 | 5 mg | $300.00 | 1 | |
Inhibits SRPK1, a kinase that phosphorylates SR proteins, which could possibly activate SRrp130 due to changes in phosphorylation status. | ||||||
Cdc2-Like Kinase Inhibitor, TG003 | 300801-52-9 | sc-202528 sc-202528A | 5 mg 25 mg | $139.00 $548.00 | 6 | |
Inhibits CLK family kinases, which could possibly activate SRrp130 by affecting the phosphorylation and activity of splicing factors. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
A CDK inhibitor that could possibly activate SRrp130 by affecting cell cycle progression and thus the activity of cell cycle-associated proteins. | ||||||